Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury

Critical Care Medicine

Volumn 39, Issue 4, 2011, Pages 711-717

  Calfee, Carolyn S ^a,b   Ware, Lorraine B ^d   Glidden, David V ^c   Eisner, Mark D ^a,b   Parsons, Polly E ^e   Thompson, B Taylor ^f,g   Matthay, Michael A ^a,b  

^a Department of Internal Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f Pulmonary and Critical Care Medicine Unit   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute respiratory distress syndrome; biological marker; pulmonary edema; risk prediction; risk reclassification

Indexed keywords

BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR RECEPTOR 1; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MORTALITY; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK RECLASSIFICATION; SCORING SYSTEM; TIDAL VOLUME;

EID: 79953202811     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318207ec3c     Document Type: Article

References (33)

1. Ware LB: Prognostic determinants of acute respiratory distress syndrome in adults: Impact on clinical trial design. Crit Care Med 2005; 33:S217-S222. (Pubitemid 40365612)
2. Ware LB, Eisner MD, Thompson BT, et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004; 170:766-772. (Pubitemid 39298992)
3. Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 35:1821-1828. (Pubitemid 47220354)
4. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1- 6; discussion 230-232. (Pubitemid 40116529)
5. Parsons PE, Matthay MA, Ware LB, et al. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 288: L426-L431. (Pubitemid 40229507)
6. Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63:1083-1089.
7. Eisner MD, Parsons P, Matthay MA, et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58:983-988. (Pubitemid 37392811)
8. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med 1983; 98:593-597. (Pubitemid 13091168)
9. Doyle RL, Szaflarski N, Modin GW, et al. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818-1824.
10. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693. (Pubitemid 41464707)
11. Erickson SE, Martin GS, Davis JL, et al. Recent trends in acute lung injury mortality: 1996 -2005. Crit Care Med 2009; 37: 1574-1579.
12. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
13. Matthay M, Brower R, Thompson B, et al. Randomized, placebo-controlled trial of an aerosolized beta-2 adrenergic agonist (albuterol) for the treatment of acute lung injury. Am J Respir Crit Care Med 2009; 179:A2166.
14. Cook NR: Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-935. (Pubitemid 46294733)
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-112. (Pubitemid 351193639)
16. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358:2107-2116. (Pubitemid 351679597)
17. Ware LB, Koyama T, Billheimer DD, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010; 137:288-296.
18. Calfee CS, Eisner MD, Parsons PE, et al. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2009; 35: 248-257.
19. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327-336.
20. Calfee CS, Eisner MD, Ware LB, et al. Trauma- associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007; 35:2243-2250. (Pubitemid 47476219)
21. Ware LB, Koyama T, Billheimer DD, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest; 2010; 137:268-296.
22. Cooke CR, Kahn JM, Caldwell E, et al. Predictors of hospital mortality in a populationbased cohort of patients with acute lung injury. Crit Care Med 2008; 36:1412-1420. (Pubitemid 351620660)
23. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk predic- tion of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636.
24. Calfee CS, Ware LB, Glidden DV, et al. Combining multiple plasma biomarkers improves risk prediction in ALI in both derivation and replication cohorts. Am J Respir Crit Care Med 2009; 179:A4626.
25. Spragg RG, Bernard GR, Checkley W, et al. Beyond mortality: Future clinical research in acute lung injury. Am J Respir Crit Care Med 2010; 181:1121-1127.
26. Molitoris BA, Melnikov VY, Okusa MD, et al. Technology insight: Biomarker development in acute kidney injury-What can we anticipate? Nat Clin Pract Nephrol 2008; 4:154-165. (Pubitemid 351312080)
27. Luyt CE, Guérin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171:48-53. (Pubitemid 40051694)
28. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631-2639. (Pubitemid 44969122)
29. Kuzniewicz MW, Vasilevskis EE, Lane R, et al. Variation in ICU risk-adjusted mortality: Impact of methods of assessment and potential confounders. Chest 2008; 133:1319-1327. (Pubitemid 351892986)
30. McClintock DE, Ware LB, Eisner MD, et al. Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med 2007; 175:256-262. (Pubitemid 46203129)
31. McClintock DE, Starcher B, Eisner MD, et al. Higher urine desmosine levels are associated with mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291:L566-L571. (Pubitemid 44498465)
32. Bajwa EK, Boyce PD, Januzzi JL, et al. Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med 2007; 35: 2484-2490. (Pubitemid 351339007)
33. Karmpaliotis D, Kirtane AJ, Ruisi CP, et al. Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 2007; 131:964-971 (Pubitemid 46608693)